Abstract

Receptor desensitization progressively limits responsiveness of cells to chronically applied stimuli. Desensitization in the continuous presence of agonist has been difficult to study with available assay methods. Here, we used a fluorescence resonance energy transfer-based live cell assay for the second messenger diacylglycerol to measure desensitization of a model seven-transmembrane receptor, the Gq-coupled angiotensin II type 1(A) receptor, expressed in human embryonic kidney 293 cells. In response to angiotensin II, we observed a transient diacylglycerol response reflecting activation and complete desensitization of the receptor within 2-5 min. By utilizing a variety of approaches including graded tetracycline-inducible receptor expression, mutated receptors, and overexpression or short interfering RNA-mediated silencing of putative components of the cellular desensitization machinery, we conclude that the rate and extent of receptor desensitization are critically determined by the following: receptor concentration in the plasma membrane; the presence of phosphorylation sites on the carboxyl terminus of the receptor; kinase activity of G protein-coupled receptor kinase 2, but not of G protein-coupled receptor kinases 3, 5, or 6; and stoichiometric expression of beta-arrestin. The findings introduce the use of the biosensor diacylglycerol reporter as a powerful means for studying Gq-coupled receptor desensitization and document that, at the levels of receptor overexpression commonly used in such studies, the properties of the desensitization process are markedly perturbed and do not reflect normal cellular physiology.

Highlights

  • Until recently our appreciation of the kinetics of 7TMR molecular pharmacology has been limited to extrapolation from either complex in vivo readouts such as changes in blood pressure or from biochemical techniques such as phosphoinositide hydrolysis assays [3], which cannot be performed in live, unperturbed cells

  • Quantification of the fluorescence resonance energy transfer (FRET) ratio time lapse (FRET intensity/monomeric Cyan fluorescent protein (CFP) intensity, To assess angiotensin II type 1A receptor (AT1AR) activation and desensitization kinetics normalized to base line) in single cells showed that AngII led to via real-time measurement of DAG, we used the fluorescent a rapid increase in DAG, followed by a biosensor DAGR [8]

  • FRET, which depends upon the distance and orientation DAGR could perturb normal AT1AR signaling

Read more

Summary

EXPERIMENTAL PROCEDURES

Plasmids—pcDNA3-DAGR and pcDNA3-CYPHER have been described previously [8]. pcDNA3.1-HA-AT1AR, pRK5GRK2 (encoding bovine GRK2), pcDNA3-␤-arrestin1-FLAG, and pcDNA3-␤-arrestin2-FLAG (encoding rat ␤-arrestins) have all been described previously [12, 13]. pcDNA3.1-HAAT1AR-13A was produced by site-directed mutagenesis of all 13 serines and threonines in the cytoplasmic tail of the receptor to alanine using appropriately designed primers and two rounds of the QuikChange kit (Stratagene) according to the manufacturer’s instructions. pTetOn and pTRE2-hyg were purchased from Clontech. Transfection of GRK2 siRNA plus 100 ng of pcDNA3-DAGR into HEK-TetOn-AT1AR cells was performed using Gene Silencer (Gene Therapy Systems) as previously described [12, 14]. Stable clones were selected based on their ability to inducibly express the AT1AR from transient transfection of pTRE2-hyg-HA-AT1AR and subsequent treatment with 1 ␮g/ml doxycycline or vehicle for 48 h. This translocation increases the effective concentration of DAGR at the membrane, resulting in increased intermolecular FRET This mechanism is distinguished from conformational change-induced intramolecular FRET changes [8]. Increasing DAGR concentration, measured by the FRET-independent YFP intensity of single transiently transfected cells, causes increasing FRET changes between untreated cells and cells treated with a saturating dose of the DAG analogue phorbol 12-myristate 13-acetate (supplemental Fig. S1A), confirming the mechanism of action of DAGR

We then used DAGR to monitor the dynamics of Angiotensin II
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call